Advertisement

Single-Agent Ibrutinib in Relapsed or Refractory Follicular Lymphoma: A Phase 2 Consortium Trial

Nancy L. Bartlett, Brian A. Costello, Betsy R. LaPlant, Stephen M. Ansell, John G. Kuruvilla, Craig B. Reeder, Lim S. Thye, Daniel M. Anderson, Kilannin Krysiak, Cody Ramirez, Jing Qi, Barry A. Siegel, Malachi Griffith, Obi L. Griffith, Felicia Gomez and Todd A. Fehniger

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted September 5, 2017
  • Accepted October 11, 2017
  • Published online October 26, 2017.


Contributors 
  • Nancy L. Bartlett, 1 Divisions of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States;
  • Brian A. Costello, 2 Mayo Clinic, Rochester, MN, United States;
  • Betsy R. LaPlant, 2 Mayo Clinic, Rochester, MN, United States;
  • Stephen M. Ansell, 2 Mayo Clinic, Rochester, MN, United States;
  • John G. Kuruvilla, 3 Princess Margaret Cancer Centre, University of Toronto, Canada;
  • Craig B. Reeder, 4 Mayo Clinic Arizona, Phoenix, AZ, United States;
  • Lim S. Thye, 5 National Cancer Center, Singapore, Singapore;
  • Daniel M. Anderson, 6 Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN, United States;
  • Kilannin Krysiak, 7 McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, United States;
  • Cody Ramirez, 7 McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, United States;
  • Jing Qi, 8 Division of Nuclear Medicine and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States;
  • Barry A. Siegel, 8 Division of Nuclear Medicine and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States;
  • Malachi Griffith, 9 Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States
  • Obi L. Griffith, 9 Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States
  • Felicia Gomez, 9 Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States
  • Todd A. Fehniger, 9 Division of Oncology and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output